Electronic Patient-Reported Outcomes (ePROS) Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
According to our new research study on “Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 –Global Analysis – by Delivery Mode, Application, End User, and Geography,” the market i... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryAccording to our new research study on “Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 –Global Analysis – by Delivery Mode, Application, End User, and Geography,” the market is anticipated to grow from US$ 843.77 million in 2023 and is projected to reach US$ 2,868.00 million by 2031; it is expected to register a CAGR of 16.5% during 2023–2031. The practice of outsourcing clinical studies with a massive rise in the number of trials and the flourishing pharmaceutical industry with a surge in research and development activities are contributing to the electronic patient-reported outcomes (ePROS) market growth. However, the data privacy and security issues hamper market growth. Further, the integration of artificial intelligence and machine learning with ePROS platforms is expected to bring new electronic patient-reported outcomes (ePROS) market trends in the coming years.North America accounted for a major share of the global electronic patient-reported outcomes (ePROS) market in 2023. The North America electronic patient-reported outcomes (ePROS) market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the increasing use of digital health technologies, which helps provide patient-centered care. This involves integrating healthcare services with software and hardware, which can be managed and monitored with the help of apps, wearable devices, and other devices. The increasing focus on chronic disease management has increased the demand for ePROs as they allow continuous assessment and timely interventions. As per the article published by the American Society of Clinical Oncology in June 2023, in the US, ePRO inclusion in the Centers for Medicare and Medicaid Innovation's alternative payment model pilot, the Enhancing Oncology Model, is a sign that ePRO implementation should be a mainstay of high-quality and transformational cancer care and is likely to foster broader adoption. The surging number of clinical trials in the country is expected to increase the demand for ePROs. Market players are taking electronic related patient outcomes (ePROS) market strategic initiatives such as product launches, product approvals, and collaborations, which are further expected to amplify the market growth. For instance, in June 2024, Evidation launched MigraineSmart, which is a health engagement experience and symptom tracking program on the Evidation app that harnesses survey data, electronic patient reported outcomes (ePROs), wearable data, and evidence-based content to make it possible for individuals to better understand and manage their migraines. Therefore, an increase in digital health technologies, a surge in demand for patient-centered care, and increase in strategic initiatives by market players are expected to fuel the growth of the ePROs Market in the coming years. The Canada electronic related patient outcomes (ePROS) market is driven by the rise in the adoption of digital health technologies and the increased use of wearables. The integration of technology in healthcare has resulted in the implementation of the electronic health record (EHR) and generated the demand for telehealth services. The government of Canada has taken initiatives to promote digital health technologies in the country. For instance, in April 2018, under the "Regulatory Review of Drugs and Devices" initiative, the Health Canada founded a new division within the Therapeutic Products Directorate's Medical Devices Bureau, which allows more targeted pre-market evaluation of digital health technologies to adapt to fast changing technologies in digital health and respond to fast innovation cycles. The increasing number of clinical trials in Canada has fueled the demand for ePROs to reduce the paperwork and increase efficiency with the help of technology. According to Innovative Medicines Canada, Canada accounts for the 3.1% in global clinical trials. Therefore, increasing adoption of digital health technologies and surging number of clinical trials have created a demand for ePROs for efficient monitoring of clinical trials driving the growth of electronic related patient outcomes (ePROS) market. Strategic Initiatives in Electronic Patient-Reported Outcomes (ePROS) to Provide Market Opportunities in Future The market for electronically reported patient outcomes (ePROs) is expected to experience lucrative opportunities with the rising adoption of telehealth and remote monitoring for clinical trials during the forecast period. Patients in remote or underserved areas can report real-time information from the comfort of their homes owing to telehealth and remote monitoring solutions, which increase accessibility of patient data. Health data can be continuously transmitted via remote monitoring devices, such as wearables and linked health systems. When coupled with ePRO systems, medical professionals receive detailed information regarding a patient's condition in real time, enabling more precise and regular interventions. For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care. The growing emphasis on patient-centered care fuels the growth of the electronic patient-reported outcomes (ePROS) market. Tools that gather patient feedback in real-time are in high demand owing to the shift toward prioritizing patient experiences, outcomes, and preferences. The real-time tracking of patient-reported health outcomes is made possible by ePROs as healthcare becomes more personalized and value-based. Better health outcomes are supported by ensuring treatments are tailored to each patient's needs. The use of digital tools such as ePROs has increased as the focus of healthcare facilities shifts to patient experience and satisfaction. With the help of this technology, patients can have less stress and receive continuous feedback by giving healthcare providers access to precise data. This change drives innovation in digital health technologies, supporting the integration of ePROs into medical procedures. For instance, healthcare providers can easily monitor patient outcomes owing to the growing integration of ePRO tools with electronic health record (EHR) systems. This facilitates the alignment of clinical decisions with the preferences and experiences that the patient has reported. Therefore, a greater understanding of patient-centered care propels the use of ePROs. Electronic Patient-Reported Outcomes (ePROS) Market: Competitive Landscape and Key Developments OpenClinica LLC, Buddy Healthcare Ltd Oy, Castor, Medable Inc, Assistek, Signant Health, Crucial Data Solutions, Curebase, Y-Prime LLC, Clinical Ink Inc, Medidata Solutions, Veeva Systems Inc, Medrio, and PatientIQ are among the key companies operating in the electronic patient-reported outcomes (ePROS) market. The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and ClinicalTrials.gov are among the primary and secondary sources referred to while preparing the electronic patient-reported outcomes (ePROS) market report. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Secondary Research 3.2 Primary Research 3.2.1 Hypothesis formulation: 3.2.2 Macro-economic factor analysis: 3.2.3 Developing base number: 3.2.4 Data Triangulation: 3.2.5 Country level data: 4. Electronic Patient-Reported Outcomes (ePROS) Market Landscape 4.1 Overview 4.2 PEST Analysis 4.3 Benefits of ePROs 4.4 Use of ePRO in Clinical Trials 4.5 List of Hospitals Using ePRO in each country 5. Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics 5.1 Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics 5.2 Market Drivers: 5.2.1 Emerging Applications of Electronic Patient-Reported Outcomes (ePROS) 5.2.2 Increasing Focus on Patient-Centered Care 5.3 Market Restraints 5.3.1 Data Privacy and Security Issues 5.4 Market Opportunities 5.4.1 Rising Adoption of Telehealth and Remote Monitoring 5.5 Future Trends 5.5.1 Integration of Artificial Intelligence and Machine Learning with ePROS Platforms 5.6 Impact of Drivers and Restraints: 6. Electronic Patient-Reported Outcomes (ePROS) Market – Global Market Analysis 6.1 Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021–2031 6.2 Electronic Patient-Reported Outcomes (ePROS) Market Forecast Analysis 7. Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Delivery Mode 7.1 Cloud Based 7.1.1 Overview 7.1.2 Cloud Based: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 7.2 On-Premise 7.2.1 Overview 7.2.2 On-Premise: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 8. Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Application 8.1 Oncology 8.1.1 Overview 8.1.2 Oncology: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 8.2 Respiratory 8.2.1 Overview 8.2.2 Respiratory: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 8.3 Others 8.3.1 Overview 8.3.2 Others: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 9. Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by End User 9.1 CROs 9.1.1 Overview 9.1.2 CROs: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 9.2 Pharmaceutical Companies 9.2.1 Overview 9.2.2 Pharmaceutical Companies: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 9.3 Others 9.3.1 Overview 9.3.2 Others: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10. Electronic Patient-Reported Outcomes (ePROS) Market – Geographical Analysis 10.1 Overview 10.2 North America 10.2.1 North America Electronic Patient-Reported Outcomes (ePROS) Market Overview 10.2.2 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.2.3 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode 10.2.4 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application 10.2.5 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User 10.2.6 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country 10.2.6.1 United States: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.2.6.1.1 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.2.6.1.2 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.2.6.1.3 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.2.6.2 Canada: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.2.6.2.1 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.2.6.2.2 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.2.6.2.3 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.2.6.3 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.2.6.3.1 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.2.6.3.2 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.2.6.3.3 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.3 Europe 10.3.1 Europe Electronic Patient-Reported Outcomes (ePROS) Market Overview 10.3.2 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.3.3 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode 10.3.4 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application 10.3.5 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User 10.3.6 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country 10.3.6.1 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.3.6.1.1 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.3.6.1.2 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.3.6.1.3 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.3.6.2 Germany: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.3.6.2.1 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.3.6.2.2 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.3.6.2.3 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.3.6.3 France: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.3.6.3.1 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.3.6.3.2 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.3.6.3.3 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.3.6.4 Italy: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.3.6.4.1 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.3.6.4.2 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.3.6.4.3 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.3.6.5 Spain: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.3.6.5.1 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.3.6.5.2 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.3.6.5.3 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.3.6.6 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.3.6.6.1 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.3.6.6.2 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.3.6.6.3 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.4 Asia Pacific 10.4.1 Asia Pacific Electronic Patient-Reported Outcomes (ePROS) Market Overview 10.4.2 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.4.3 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode 10.4.4 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application 10.4.5 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User 10.4.6 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country 10.4.6.1 Japan: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.4.6.1.1 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.4.6.1.2 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.4.6.1.3 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.4.6.2 China: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.4.6.2.1 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.4.6.2.2 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.4.6.2.3 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.4.6.3 India: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.4.6.3.1 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.4.6.3.2 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.4.6.3.3 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.4.6.4 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.4.6.4.1 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.4.6.4.2 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.4.6.4.3 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.4.6.5 Australia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.4.6.5.1 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.4.6.5.2 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.4.6.5.3 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.4.6.6 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.4.6.6.1 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.4.6.6.2 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.4.6.6.3 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.5 South & Central America 10.5.1 South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Overview 10.5.2 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.5.3 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode 10.5.4 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application 10.5.5 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User 10.5.6 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country 10.5.6.1 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.5.6.1.1 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.5.6.1.2 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.5.6.1.3 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.5.6.2 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.5.6.2.1 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.5.6.2.2 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.5.6.2.3 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.5.6.3 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.5.6.3.1 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.5.6.3.2 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.5.6.3.3 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.6 Middle East & Africa 10.6.1 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Overview 10.6.2 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.6.3 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode 10.6.4 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application 10.6.5 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User 10.6.6 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country 10.6.6.1 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.6.6.1.1 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.6.6.1.2 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.6.6.1.3 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.6.6.2 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.6.6.2.1 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.6.6.2.2 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.6.6.2.3 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.6.6.3 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.6.6.3.1 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.6.6.3.2 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.6.6.3.3 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 10.6.6.4 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) 10.6.6.4.1 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode 10.6.6.4.2 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application 10.6.6.4.3 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User 11. Electronic Patient-Reported Outcomes (ePROS) Market – Industry Landscape 11.1 Overview 11.2 Growth Strategies in Electronic Patient-Reported Outcomes (ePROS) Market 11.3 Organic Growth Strategies 11.3.1 Overview 11.4 Inorganic Growth Strategies 11.4.1 Overview 12. Company Profiles 12.1 OpenClinica LLC 12.1.1 Key Facts 12.1.2 Business Description 12.1.3 Products and Services 12.1.4 Financial Overview 12.1.5 SWOT Analysis 12.1.6 Key Developments 12.2 Buddy Healthcare Ltd Oy 12.2.1 Key Facts 12.2.2 Business Description 12.2.3 Products and Services 12.2.4 Financial Overview 12.2.5 SWOT Analysis 12.2.6 Key Developments 12.3 Castor 12.3.1 Key Facts 12.3.2 Business Description 12.3.3 Products and Services 12.3.4 Financial Overview 12.3.5 SWOT Analysis 12.3.6 Key Developments 12.4 Medable Inc 12.4.1 Key Facts 12.4.2 Business Description 12.4.3 Products and Services 12.4.4 Financial Overview 12.4.5 SWOT Analysis 12.4.6 Key Developments 12.5 Assistek 12.5.1 Key Facts 12.5.2 Business Description 12.5.3 Products and Services 12.5.4 Financial Overview 12.5.5 SWOT Analysis 12.5.6 Key Developments 12.6 Signant Health 12.6.1 Key Facts 12.6.2 Business Description 12.6.3 Products and Services 12.6.4 Financial Overview 12.6.5 SWOT Analysis 12.6.6 Key Developments 12.7 Crucial Data Solutions 12.7.1 Key Facts 12.7.2 Business Description 12.7.3 Products and Services 12.7.4 Financial Overview 12.7.5 SWOT Analysis 12.7.6 Key Developments 12.8 Curebase 12.8.1 Key Facts 12.8.2 Business Description 12.8.3 Products and Services 12.8.4 Financial Overview 12.8.5 SWOT Analysis 12.8.6 Key Developments 12.9 Y-Prime LLC 12.9.1 Key Facts 12.9.2 Business Description 12.9.3 Products and Services 12.9.4 Financial Overview 12.9.5 SWOT Analysis 12.9.6 Key Developments 12.10 Clinical Ink Inc 12.10.1 Key Facts 12.10.2 Business Description 12.10.3 Products and Services 12.10.4 Financial Overview 12.10.5 SWOT Analysis 12.10.6 Key Developments 12.11 Medidata Solutions 12.11.1 Key Facts 12.11.2 Business Description 12.11.3 Products and Services 12.11.4 Financial Overview 12.11.5 SWOT Analysis 12.11.6 Key Developments 12.12 Veeva Systems Inc 12.12.1 Key Facts 12.12.2 Business Description 12.12.3 Products and Services 12.12.4 Financial Overview 12.12.5 SWOT Analysis 12.12.6 Key Developments 12.13 Medrio 12.13.1 Key Facts 12.13.2 Business Description 12.13.3 Products and Services 12.13.4 Financial Overview 12.13.5 SWOT Analysis 12.13.6 Key Developments 12.14 PatientIQ 12.14.1 Key Facts 12.14.2 Business Description 12.14.3 Products and Services 12.14.4 Financial Overview 12.14.5 SWOT Analysis 12.14.6 Key Developments 13. Appendix 13.1 About Us 13.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
The Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(asia)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/25 10:26 153.16 円 166.17 円 201.34 円 |